Patents Assigned to Nobuhiro Narita
  • Patent number: 5795871
    Abstract: 14- or 15-membered-ring macrolide compounds such as clarithromycin, erythromycin B, etc. have a potent antitumor effect on non-small cell lung cancers which are considered the most difficult tumors to be be subjected to surgical operation and chemotherapy, and are useful as a practical therapeutic agent of non-small cell lung cancer.
    Type: Grant
    Filed: October 23, 1996
    Date of Patent: August 18, 1998
    Assignee: Nobuhiro Narita
    Inventors: Nobuhiro Narita, Masayoshi Sawaki, Keiichi Mikasa, Eiji Kita